(Q36668242)

15 August 2017

1 reference

title

Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas (English)

1 reference

15 August 2017

1 reference

Candelaria Gomez-Manzano

series ordinal

3

object named as

Candelaria Gomez-Manzano

1 reference

15 August 2017

5

Juan Fueyo

1 reference

15 August 2017

Hong Jiang

1

1 reference

15 August 2017

Marta M Alonso

series ordinal

2

1 reference

15 August 2017

Yuji Piao

series ordinal

4

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

1585-1592

1 reference

Epidemiology and etiology of gliomas

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Novel radiation-enhancing agents in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Oncolytic adenoviruses as antiglioma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Interactions of viruses with the cellular DNA repair machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Pharmacological strategies to increase the antitumor activity of methylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

DNA break repair: refined rules of an already complicated game

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Human mismatch repair, drug-induced DNA damage, and secondary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Deletion of the E4 region of the genome produces adenovirus DNA concatemers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Molecular regulation and biological function of adenovirus early genes: the E4 ORFs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

The Mre11 complex is required for ATM activation and the G2/M checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Regulation of the human O(6)-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Detection of HSV-1 genome in central nervous system of latently infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Relationship of herpes simplex virus genome configuration to productive and persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

ICP0, a regulator of herpes simplex virus during lytic and latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

DNA repair proteins affect the lifecycle of herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Inactivation of Ku-mediated end joining suppresses mec1Delta lethality by depleting the ribonucleotide reductase inhibitor Sml1 through a pathway controlled by Tel1 kinase and the Mre11 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

The Dun1 checkpoint kinase phosphorylates and regulates the ribonucleotide reductase inhibitor Sml1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

The role of DNA recombination in herpes simplex virus DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Myeloid differentiation (MyD) primary response genes in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1585

10.1586/14737140.6.11.1585

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference